Medtronic CEO Omar Ishrak on Covidien deal, value based healthcare at LSA2014

In case you missed it

• Access Vascular logs GPO win with Premier contract
• FDA joins ‘collaborative communities’
• TAVR technique cuts pacemaker implantation rate
• Ambrosia app links Abbott’s FreeStyle Libre with Fitbit wearable
• How can medical device companies thrive in the future?
• Synchron touts first-in-human implantation for brain-computer interface
• Balt parent escapes Neurvana Medical sabotage suit
• FDA IDs first devices for expedited 510(k) clearance review
• Zimmer Biomet, Align Technology ink distribution deal
• Report: Medtronic plans 100 more layoffs in shift from California to Massachusetts
• Integra Lifesciences touts Cadence ankle study
• Active Implants wins breakthrough nod for NUsurface knee implant
• Key questions for medical device companies to tackle gaps in cybersecurity processes
• Where are the world’s medtech headquarters?
• Tandem Diabetes Care touts real-world t:slim X2 insulin pump data
• FDA clears Viseon’s Voyant spine surgery imaging device
• Covalon closes $6m private placement